ClinicalTrials.gg
Drug

Glimepiride clinical trials

Also written Amaryl.

studies test it
73
open now
2
in phase 3
20
first study started
2000

How each study uses glimepiride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the glimepiride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Nov 1995 · AMARYL · NDA 020496 (FDA, Drugs@FDA)
European Union
27 Jun 2006 · Avaglim · EMEA/H/C/000675 (EMA; in a combination; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Glimepiride
42
Glimepiride Tablets 1 mg
3
Glimepiride 4 mg Tablets
2
Glimepiride Tablets
2
Glimepiride (HOE490)
2

Brand

Amaryl
13
Amaryl 4 mg
1

Development codes

HOE490
1

In one entry with another drug

Given together, or one or the other

GLIMEPIRIDE + METFORMIN
2
Pioglitazone and Glimepiride
2

Studies by the year they started

73 studies that test it; most in 2003 (8)

Studies that test glimepiride, by start year
YearStudies
20001
20012
20023
20038
20042
20054
20064
20072
20084
20096
20103
20114
20124
20133
20143
20157
20162
20174
20203
20221
20231
20262

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
2
Phase 3
20
Phase 4
29
No phase
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 46 · Other 27

Sanofi (11) · AstraZeneca (4) · Novo Nordisk A/S (4) · Laboratorios Silanes S.A. de C.V. (3) · Teva Pharmaceuticals USA (2) · Mylan Pharmaceuticals Inc (2) · Theracos (2) · GlaxoSmithKline (2)

Often tested with

Tested in the same studies.

Metformin (22) · Sitagliptin (7) · Insulin Glargine (5) · Dapagliflozin (5) · Vildagliptin (4) · Saxagliptin (4) · Liraglutide (4) · Pioglitazone (4)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses glimepiride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 73

See all 73 studies that test glimepiride →

Given beside what is tested · 39 — glimepiride is usual care or a partner of the new treatment

Showing 20 of 39.

As the comparator · 76 — what is tested is compared with glimepiride

Showing 20 of 76.

Codes

What other systems call glimepiride · ClinicalTrials.gg INT003395

  • MeSH (NLM) C057619glimepirideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6KY687524KGLIMEPIRIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 25789Confirmed FDA, Wikidata
  • Wikidata Q106029845glimepirideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29073GlimepirideOne source FDA
  • DrugBank DB00222One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.